Hamostaseologie

Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.

Laboratory Diagnostics in Thrombophilia.

Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients.

Impact of Telemedicine Tools on Record Keeping and Compliance in Haemophilia Care.

The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019?

Causes and Secondary Prevention of Acute Ischemic Stroke in Adults.

Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.

Low-Molecular-Weight Heparin in Cancer Patients: Overview and Indications.

Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach towards Precision Medicine in Thrombotic Disease.

Coagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models.

How Do We Treat Pregnancy-Related Venous Thromboembolism?

MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.

First-Line Therapy for Immune Thrombocytopenia.

Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.

Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.

Diagnosing Immune Thrombocytopenia.

Trauma-Induced Coagulopathy.

Smart Medication ™, an Electronic Diary for Surveillance of Haemophilia Home Care and Optimization of Resource Distribution.

Antibodies in the Treatment of Haemophilia A-A Biochemical Perspective.

Fulminant Essential Thrombocythemia Associated with Acquired Von Willebrand Syndrome and Bleeding Episodes in a 14-year-old Girl.

Therapie des Antiphospholipid-Syndroms (APS) mit DOAKs

[Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren].

Acquired Haemophilia A Associated with Subsequent Hepatocellular Carcinoma.

Immunomodulatory Second-Line Therapies for Immune Thrombocytopenia.

Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years.

Child Abuse or Bleeding Disorder-An Interdisciplinary Approach.

Current Trend of Invasive Orthopaedic Interventions for People with Haemophilia in Romania: Single Centre Experience.

Thrombopoietin Receptor Agonist Use for Immune Thrombocytopaenia.

Translational Research in Thrombosis and Haemostasis.

Replacement Therapy in Patients with Von Willebrand Disease-Indications and Monitoring.

Development of Haemophilia Treatment in the Eastern Part of Germany over the Last Decade in the Kompetenznetz Hämorrhagische Diathese Ost (KHDO).

IWR-1 Inhibits Collagen-Induced Platelet Activation and Protects against Thrombogenesis.

A Sardinian Family with Factor XI Deficiency.

Immune Thrombocytopenia-A Disease or a Group of Disorders? Where Do We Stand in 2019?

A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience.

A Prolonged Treatment Response in Acquired Von Willebrand Syndrome.